Cargando…

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET

PURPOSE: Measurement of heterogeneity in (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) images is reported to improve tumour phenotyping and response assessment in a number of cancers. We aimed to determine whether measurements of (18)F-FDG heterogeneity could improve differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Gary J. R., Lovat, Eitan, Siddique, Muhammad, Goh, Vicky, Ferner, Rosalie, Warbey, Victoria S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644685/ https://www.ncbi.nlm.nih.gov/pubmed/28589254 http://dx.doi.org/10.1007/s00259-017-3733-1

Ejemplares similares

The effect of post-injection (18)F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
por: Lovat, Eitan, et al.
Publicado: (2017)

Measurement of (18)F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model
por: Bashir, Usman, et al.
Publicado: (2019)

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018)

Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT
por: Salamon, Johannes, et al.
Publicado: (2015)

Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
por: Geitenbeek, Ritch T. J., et al.
Publicado: (2022)

Malignant peripheral nerve sheath tumour in a patient with a plexiform neurofibromatosis
por: Nekkanti, Ravi, et al.
Publicado: (2015)

The effects of segmentation algorithms on the measurement of (18)F-FDG PET texture parameters in non-small cell lung cancer
por: Bashir, Usman, et al.
Publicado: (2017)

Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1
por: Thomas, Laura, et al.
Publicado: (2012)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
por: Carton, Charlotte, et al.
Publicado: (2023)

Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours
por: Porter, D. E., et al.
Publicado: (2009)

Neurofibromatosis type 1‐associated malignant peripheral nerve sheath tumour carcinomatous pleurisy: an autopsy case
por: Furukawa, Marie, et al.
Publicado: (2019)

Reliability of functional outcome measures in adults with neurofibromatosis 1
por: Mullin, Rebecca L, et al.
Publicado: (2018)

The Role of [(18)F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1
por: Tovmassian, David, et al.
Publicado: (2016)

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients
por: Liu, Jun, et al.
Publicado: (2022)

Malignant Peripheral Nerve Sheath Tumor Arising from Neurofibromatosis
por: Lee, Dae-Sung, et al.
Publicado: (2013)

Nerve sheath tumours
por: Robertson, James A., et al.
Publicado: (2018)

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
por: Sharkey, Amy R., et al.
Publicado: (2021)

Challenges and Promises of PET Radiomics
por: Cook, Gary J.R., et al.
Publicado: (2018)

Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours
por: Thomas, Laura E, et al.
Publicado: (2015)

The utility of (18)F-FDG PET/CT in brain tumours diagnosis
por: Pietrzak, Agata, et al.
Publicado: (2022)

Malignant Peripheral Nerve Sheath Tumors in Children with Neurofibromatosis Type 1
por: Pourtsidis, Apostolos, et al.
Publicado: (2014)

Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
por: Brahmi, Mehdi, et al.
Publicado: (2015)

The value of 18F-FDG PET/CT in patient with neurofibromatosis type 1: A case report and literature review
por: Ren, Jiazhong, et al.
Publicado: (2018)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

Essential Nerve-Sheath Tumours
Publicado: (1930)

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
por: Connor, Steve, et al.
Publicado: (2021)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
por: Combemale, Patrick, et al.
Publicado: (2014)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
por: Byrne, Susan, et al.
Publicado: (2017)

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
por: Westerland, Olwen, et al.
Publicado: (2021)

(18)F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodie’s abscess
por: Fathinul, F, et al.
Publicado: (2010)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET
por: Townley, Ryan A, et al.
Publicado: (2021)

Identifying challenges in neurofibromatosis: a modified Delphi procedure
por: Dhaenens, Britt A. E., et al.
Publicado: (2021)

Cranial nerve and intramedullary spinal malignant peripheral nerve sheath tumor associated with neurofibromatosis-1
por: Newell, Christopher, et al.
Publicado: (2021)

Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1
por: Janardhanan, Mahija, et al.
Publicado: (2011)

Huge Intrathoracic Malignant Peripheral Nerve Sheath Tumor in an Adolescent with Neurofibromatosis Type 1
por: Yoon, Jong Hyung, et al.
Publicado: (2014)

Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor in the Nasal Cavity
por: Marini, Katerina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1njhiagkp557b1hhqdcvmec3qg